The outcomes following Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion (PETLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery (MIS-TLIF) for the treatment of lumbar disease: a randomized controlled trial
Phase 4
Recruiting
- Conditions
- Patients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis.Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion, PETLIF, Endo-TLIF, Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery, MIS-TLIF, TLIF, Degenerative Lumbar disease
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
1.Age over 18 yr with consent to ethics
2.Patients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis
3.Patients who diagnosed Degenerative Lumbar disease with dynamic radiographs, computed tomography scan, magnetic resonance imaging
4.Patients were treated with fully medical and rehabilitation threrapy at least 3 months, which is clinical outcomes not improve
Exclusion Criteria
1.Patients who had a history of prior to spine surgery
2.Patients who rejected or withdrawed from research protocol
3.Patients who had a clinical of caudal equina syndrome
4.Patients who had a history of recent spine infection or others systemic infection
5.Patients who had a history of coagulopathy or anemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method functional outcomes 12 months after end of the intervention VisualAnalogScale, Oswestry Disability Index
- Secondary Outcome Measures
Name Time Method QOL, sagittal balance, fusion rate 12 months after end of the intervention Modified Macnab criteria score, plain film X ray, CT scan